Valuation: Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Capitalization 39TCr 5.6TCr 4.72TCr 4.3TCr 4.11TCr 7.62TCr 5,06900Cr 7.92TCr 50TCr 20TCr 2,44800Cr 21TCr 21TCr 8,55500Cr P/E ratio 2025 *
44.3x
P/E ratio 2026 * 39.6x
Enterprise value 35TCr 5.04TCr 4.25TCr 3.87TCr 3.7TCr 6.86TCr 4,56400Cr 7.13TCr 45TCr 18TCr 2,20400Cr 19TCr 19TCr 7,70300Cr EV / Sales 2025 *
10.6x
EV / Sales 2026 * 9.3x
Free-Float
52.38%
Yield 2025 *
0.45%
Yield 2026 * 0.52%
1 day-0.87%
1 week+1.61%
Current month+0.12%
1 month-9.75%
3 months-8.39%
6 months-7.00%
Current year-2.25%
1 week 57
Extreme 57
59.95
1 month 56.08
Extreme 56.08
63.83
Current year 56.08
Extreme 56.08
65.83
1 year 44.2
Extreme 44.2
74.04
3 years 35.51
Extreme 35.51
74.04
5 years 27
Extreme 27
92.83
10 years 13.59
Extreme 13.5866
97.39
Manager TitleAgeSince
Director of Finance/CFO 49 19/11/2021
President - 02/04/2025
Compliance Officer 34 01/06/2021
Director TitleAgeSince
Director/Board Member 56 16/01/2020
Director/Board Member 50 16/01/2020
Chairman 67 08/07/2021
Change 5d. change 1-year change 3-years change Capi.($)
-0.87%+1.61%+30.44%+29.49% 5.6TCr
+0.33%-1.72%+23.18%+199.23% 93TCr
-0.45%+1.44%+55.91%+50.24% 59TCr
+1.76%+3.61%+20.03%+51.71% 41TCr
+0.08%+1.01%+20.89%+28.94% 37TCr
+1.42%+7.19%+26.36%+32.36% 32TCr
+1.08%+4.32%+27.98%+55.61% 31TCr
+1.82%-0.43%+46.26%+11.65% 30TCr
+1.32%+5.11%-45.12%-37.51% 22TCr
+1.52%-3.94%+26.80%+53.17% 20TCr
Average +0.80%+1.94%+23.27%+47.49% 37.05TCr
Weighted average by Cap. +0.72%+1.58%+26.60%+76.04%

Financials

2025 *2026 *
Net sales 3.29TCr 476.86Cr 401.81Cr 366.48Cr 349.88Cr 649.48Cr 43TCr 674.81Cr 4.26TCr 1.69TCr 21TCr 1.79TCr 1.75TCr 73TCr 3.67TCr 531.41Cr 447.77Cr 408.4Cr 389.91Cr 723.77Cr 48TCr 752Cr 4.75TCr 1.89TCr 23TCr 1.99TCr 1.95TCr 81TCr
Net income 799.3Cr 115.7Cr 97Cr 89Cr 85Cr 157.58Cr 10TCr 163.72Cr 1.03TCr 410.57Cr 5.06TCr 433.89Cr 424.97Cr 18TCr 1.02TCr 147.72Cr 124.47Cr 113.53Cr 108.38Cr 201.19Cr 13TCr 209.04Cr 1.32TCr 524.19Cr 6.46TCr 553.97Cr 542.58Cr 23TCr
Net Debt -3.85TCr -557.49Cr -469.74Cr -428.45Cr -409.04Cr -759.3Cr -50TCr -788.91Cr -4.98TCr -1.98TCr -24TCr -2.09TCr -2.05TCr -85TCr -4.51TCr -653.39Cr -550.55Cr -502.15Cr -479.4Cr -889.91Cr -59TCr -924.61Cr -5.84TCr -2.32TCr -29TCr -2.45TCr -2.4TCr -1LCr
Logo Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Jiangsu Hengrui Medicine Co., Ltd. specializes in the research, development, manufacture and marketing of pharmaceutical products. The activity is organized primarily around 5 families of products: - anti-tumor drugs (No. 1 Chinese); - Anesthetic drugs; - contrast agents: used in medical imaging; - anti-inflammatory drugs; - drugs for the treatment of cardiovascular diseases.
Employees
20,238
Date Price Change Volume
13/26/13 58.23 ¥ -0.87% 3,43,56,810
12/26/12 58.74 ¥ -0.27% 3,48,68,980
11/26/11 58.90 ¥ +0.86% 5,73,68,000
10/26/10 58.40 ¥ +1.65% 6,48,86,060
09/26/09 57.45 ¥ +0.24% 3,66,11,680
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
58.23CNY
Average target price
82.57CNY
Spread / Average Target
+41.80%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600276 Stock